antibody screening was repeated with reagent red cells from another manufacturer (3% red cell suspension, Surgiscreen ® , Ortho Clinical Diagnostics, USA) and in-house antibody screening cells (phenotyped for clinically significant antigens) which was negative. The antibiotics used in Surgiscreen were a combination of chloramphenicol, neomycin, and gentamicin. The serum was reactive with the reagent containing the drug in question and nonreactive with the reagent without the drug (in-house and another manufacturer). Overall findings were compatible with the cotrimoxazole-induced antibody. The patient denied any history of drug intake in the past. There was no feature of hemolysis.
Antibody to a preservative component in a commercial red blood cell (RBC) reagent should be suspected when there patient's serum is pan-reactive with commercial screening or panel red cells but not with donor red cells at the same phase of testing. [1] These antibodies react at both saline and Coombs phases of testing. Adenine, glucose, inosine, sodium citrate, and sodium chloride are among the preservatives commonly used in these reagents. The bacteriostatic agents included in these reagents are chloramphenicol, gentamycin, neomycin, vancomycin, paraben, sodium azide and steroids, a combination of trimethoprim and sulfamethoxazole (cotrimoxazole). Antibodies to these drugs interfering with immunohematology tests have been described earlier. Such interference has been documented with antibodies used in commercial antisera, red cells, and potentiators. [2] The cotrimoxazole-induced antibody is a drug-dependent antibody, that is, the presence of the drug is needed to detect the drug-induced antibodies. [3] Patients may have drug-induced antibodies in the serum. These antibodies cause false-positive reactions with commercial red cell panel, thereby complicating the compatibility testing. These reactions are mainly observed in vitro and are thought to carry no clinical significance. These drugs act mainly by binding to the red cell membrane (drug-membrane components). [4] These drugs probably get anchored to a membrane glycoprotein. Pham et al. proposed that the drugs trimethoprim and sulfamethoxazole may attach to Kell glycoprotein and H substance, respectively. [5] The bound drug then elicits drug-dependent and drug-independent reactions resulting in immune hemolysis. LISS also contains cotrimoxazole as a preservative. The addition of LISS alone could not result in agglutination of the donor red cells which could be explained by the following reasons: (1) the presence of drug-coated RBCs in the reagent. Six times washing of the reagent red cells was unsuccessful in the removing the drug and (2) also, the concentration of the drug in red cell reagent and LISS is unknown. [2] In the present case, the patient denied any history of drug intake in the past. Drug-induced antibodies have been reported even in the sera of healthy donors and random patients. It is thought to be related to the prophylactic use of antimicrobial drugs in cattle feed. Longtime exposure to the drugs could also occur through contaminated water and air. [4] Transfusion Medicine Department personnel should be aware of this rare phenomenon, especially when they use fully automated platform for blood grouping and "type and screen" policy for compatibility testing. Patch et al. recommended simple solutions (mainly CTT) to avert the unnecessary time delay in releasing the blood. [1] conclusIon Antibiotics are included in the commercial reagents to inhibit bacterial growth. The presence of antibodies to these drugs in a patient's serum, even in healthy individuals, is not an uncommon phenomenon. [5] Antibiotic-dependent antibody should be suspected when the serum is reactive with commercial red cells (containing the antibiotic) and not with the donor red cells (not containing the antibiotic). It is strongly emphasized to include CTT in such cases, facilitating timely provision of blood to these patients.
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